Virus lab ready in Tvm but underused
: Kerala's experience in handling the pandemic has enhanced its
, with the
(IAV) in Thonnakkal, Thiruvananthapuram, now capable of testing 85 viral parameters. Established in 2020, the institute is equipped to detect viruses of both regional and global concern—including vector-borne, respiratory, zoonotic, and encephalitis-causing pathogens.Despite its capabilities, samples are often not routed to the IAV.
Tired of too many ads? go ad free now
For instance, in the recent Nipah case in Malappuram's Valanchery, the sample was first tested at Kozhikode's Microbiology Lab and then sent to Pune's National Institute of Virology.However, IAV Director Dr E Sreekumar confirmed that the institute is fully equipped to test Nipah and has even introduced
for rapid response during outbreaks. "The mobile units are designed for quick infection testing during widespread outbreaks," he said.The stated aim of the institute is to help strengthen the public health system and pandemic preparedness of the state by effective surveillance and detection of emerging and re-emerging viruses. It is equipped to conduct outbreak investigation, molecular epidemiology research, diagnostic kit development, virology training, and collaboration with medical colleges and research centres.A senior doctor pointed out that while norms require WHO-accredited labs to confirm new outbreaks, Nipah is no longer new and Kerala's own facilities should suffice.
Four years since its launch, the institute has made key scientific progress, including developing non-Nipah-like virus particles — a major step towards creating vaccines and monoclonal antibodies.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Print
2 hours ago
- The Print
MBBS Abroad Just Got Easier: Philippines Emerges as a Game-Changer for Indian Students
New Delhi [India], June 5: As the NEET UG 2025 results approach, Indian students face tough decisions regarding medical education options amid limited government seats and high private college fees. In this context, the Philippines is emerging as a key destination for Indian students seeking MBBS degrees abroad. In a recent move aimed at promoting tourism, the Philippines government announced visa-free entry for Indian nationals for stays of up to 14 days. While primarily intended to boost tourism, this new policy has presented an unexpected advantage for Indian students and their families considering medical education in the country. The visa-free window allows them to visit campuses, interact with faculty, understand the academic environment, and evaluate infrastructure–without the burden of undergoing a lengthy visa process. 'Being able to see and feel where you're going to study — that changes everything for families making this important decision,' says Kadwin Pillai, Managing Director of Transworld Educare and Director of Kings International Medical Academy. 'The Philippines is not just welcoming students; it's giving them the confidence to choose wisely.' The Philippines has steadily gained popularity among Indian medical aspirants due to its unique advantages. One of the key draws is that the medium of instruction is English, eliminating the language barriers that often deter students from considering non-English-speaking countries. Additionally, the medical curriculum in the Philippines is based on the US education system, which offers an international standard of learning and exposure. Another significant advantage is the clinical training that students receive during their course. The Philippines has a tropical climate and disease patterns that are similar to those in India. This means Indian students studying there are exposed to medical conditions they are likely to encounter in their future practice back home, providing them with valuable and relevant clinical experience. Cost is another crucial factor influencing the decision. Studying MBBS in the Philippines is substantially more affordable compared to private medical colleges in India or even other popular international destinations like the USA, UK, or Australia. Tuition fees, living expenses, and other costs are comparatively lower, making it an accessible option for a broader segment of Indian students. The country has also taken progressive steps to reform its medical education system. Recent updates to the Philippines Medical Act now allow international graduates from CHED-accredited (Commission on Higher Education) institutions to register and practice medicine in the country after completing their internship. These reforms are seen as a step forward in aligning the country's medical education with international standards and enhancing its global appeal. For Indian students, this development is particularly important. The updated policy is in line with the Indian Medical Commission's framework, which means students can choose to either pursue a career in the Philippines or return to India and appear for the Foreign Medical Graduate Examination (FMGE) or NEXT, as required by Indian regulatory bodies. Industry experts suggest that the visa exemption comes at a crucial time. With over 20 lakh students appearing for NEET UG annually and only about one lakh government MBBS seats available, many students inevitably look toward foreign universities. The ability to physically visit institutions and make informed decisions before committing to a multi-year course is expected to positively impact the decision-making process. Currently, several CHED-accredited medical institutions in the Philippines are actively enrolling Indian students. In response to increasing demand, many universities have started offering additional support services, including Indian food, academic counselling, and preparation guidance for Indian licensing exams. These initiatives are aimed at easing the transition for Indian students and creating a more supportive academic environment. As student interest grows, the Philippines continues to strengthen its position as a medical education hub in Asia through ongoing policy reforms, improved accessibility, and cultural openness. The country's friendly diplomatic ties with India further support this dynamic, making it easier for students and institutions to collaborate across borders. As Indian students prepare for their next steps after NEET UG 2025, the Philippines stands out as a practical and accessible option for those seeking a quality medical education abroad offering a compelling mix of affordability, academic credibility, and supportive policy frameworks. (ADVERTORIAL DISCLAIMER: The above press release has been provided by SMPL. ANI will not be responsible in any way for the content of the same) This story is auto-generated from a syndicated feed. ThePrint holds no responsibility for its content.
Hindustan Times
2 hours ago
- Hindustan Times
86.5 lakh deaths in 2022, 15 pc dip over Covid-hit 2021: CRS data
New Delhi, Nearly 86.5 lakh deaths were reported in the country during 2022, a significant decline of more than 15 per cent from Covid-affected 2021 which had recorded over 1.02 crore deaths, according to a new data from the Civil Registration System . The dip of 15.74 lakh from 2021 brought mortality figures broadly back in line with pre-pandemic patterns last seen in 2020, the data for 2022 brought out by the office of the Registrar General of India through CRS report showed. According to the CRS data, 2021 registered a sharp spike with 1.02 crore deaths across the country as compared to 81.1 lakh in 2020, 76.4 lakh in 2019, and 69.5 lakh in 2018, underscoring the impact of COVID-19. "In the case of registered deaths, the number has decreased from 102.2 lakh in 2021 to 86.5 lakh in 2022, i.e. a decrease of 15.4 per cent. Some of the major states namely, Gujarat, Maharashtra, Madhya Pradesh, Andhra Pradesh, Tamil Nadu, Uttar Pradesh, Karnataka, West Bengal, Bihar and Haryana have contributed significantly to the decreased number of registered deaths," the report said. Around 5.26 lakh deaths were reported due to COVID-19 till July 26, 2022, according to a reply given by the government in the Lok Sabha on July 29, 2022. The World Health Organisation had reported over 47 lakh COVID-19 linked deaths in India which was strongly disputed by the government. The Centre had said the WHO estimates suffered from "a number of inconsistencies and erroneous assumptions". "India had registered a strong objection to the process, methodology and outcome of this unscientific modelling approach especially when India had provided authentic data published through Civil Registration System by Registrar General of India to WHO," the government reply had said. The CRS report also showed that over 2.54 crore births were registered in 2022. "The number of registered births has increased from 242.0 lakh in 2021 to 254.4 lakh in 2022, an increase of about 5.1 per cent," the report said. There has been an increase in 2022 in registered births in almost all states and UTs, except Bihar, Haryana, Himachal Pradesh, Sikkim, West Bengal, Ladakh, and Lakshadweep as compared to 2021. Nine major states namely, Uttar Pradesh, Madhya Pradesh, Maharashtra, Jharkhand, Karnataka, Gujarat, Telangana, Chhattisgarh and Assam have contributed significantly to the increase in registered births in 2022 over 2021, the report said. "On the other hand, decrease in registered births in six figures has been observed in two major states namely, West Bengal and Bihar during 2021-2022," it said.
&w=3840&q=100)
First Post
2 hours ago
- First Post
Dr explains: Why booster shots are crucial even with mild Covid-19 symptoms prevailing
India is experiencing a mild surge in COVID-19 cases driven by new Omicron subvariants, with mostly mild symptoms and low hospitalizations. Experts stress the importance of boosters, surveillance and protecting vulnerable groups. Firstpost brings out a doctor's view on symptoms, vaccine effectiveness, and the country's preparedness in tackling the evolving situation. read more According to the Ministry of Health and Family Welfare, India's active Covid-19 cases have reached 5,364 as of Friday, with Kerala remaining the most affected state, reporting over 1,600 active cases. Gujarat, West Bengal, and Delhi follow, with Delhi recording 592 active cases while conducting an average of 1,200 RT-PCR tests daily. The recent surge is primarily driven by newer Omicron subvariants. Firstpost talked to Dr. Diksha Goyal, Consultant – Internal Medicine, Marengo Asia Hospital, Gurugram to shed light on the current Covid-19 scenario, the impact of emerging variants and what people need to know. STORY CONTINUES BELOW THIS AD Reports indicate new variants like LF.7, XFG, JN.1, and NB.1.8.1 are driving the surge. Which of these are currently most prevalent in India? The JN.1 subvariant of Omicron is currently the most widespread in India. Other variants like LF.7, XFG, and NB.1.8.1 are present but less common. All appear to cause mild, self-limiting infections, with no significant rise in severe cases or hospitalisation. Are there any emerging symptoms that differ from previous Covid-19 waves? Yes, while traditional symptoms like fever and cough persist, new symptoms such as hoarseness, sore throat, fatigue, and mild gastrointestinal issues (like nausea or diarrhoea) are increasingly reported. These variants may feel milder but remain highly transmissible. How do current case and hospitalisation numbers compare to earlier waves? The current surge is far less severe than previous waves. Most infections are mild, and the healthcare system is not under strain. Authorities are maintaining readiness, but infrastructure and critical care services are coping well. How deadly are these new variants compared to earlier ones like Delta or previous Omicron strains? Clinically, the newer variants are more contagious but less lethal than the Delta variant. Symptoms are often milder than or similar to previous Omicron subvariants, particularly in vaccinated individuals. However, those at higher risk should remain cautious. The WHO has classified NB.1.8.1 as a 'Variant Under Monitoring.' What does this mean? This label signals genetic changes that could affect how the virus behaves, including its ability to spread or evade immunity. While not currently a major threat, it warrants close observation in case of any future risk. Are specific groups more vulnerable to severe illness with these new variants? Yes. Older adults, immunocompromised individuals, pregnant women, and children remain more susceptible to complications. Their immune systems may be weaker or still developing, so vaccination and preventive measures are essential. With waning immunity, what's your advice on booster doses? Booster shots are crucial, especially for high-risk people. They help sustain protection, reduce the severity of illness, and lower the chance of hospitalisation. Staying up to date with boosters remains a key preventive strategy. How effective are current vaccines against these variants? Do we need new formulations? Existing vaccines still offer strong protection against severe illness, hospitalisation, and death. While they may be less effective at preventing infection, they remain beneficial. Updated formulations targeting newer variants could enhance this protection further. What about people with 'hybrid immunity' from both vaccination and infection? Hybrid immunity offers stronger, more durable protection than either vaccination or infection alone. It significantly reduces the risk of severe illness. However, this immunity may wane over time, so periodic boosters are still recommended. How important is genomic surveillance? Is India prepared? Ongoing surveillance and sequencing are vital for tracking new variants and guiding public health responses. India has ramped up its genomic capabilities, but sustained funding, coordination, and vigilance are needed to remain prepared for future waves. Could Covid-19 become seasonal like the flu? That's a strong possibility. Covid-19 may eventually become endemic with periodic surges, much like influenza. The pattern will depend on factors such as mutations, immunity levels, and public health responses. What key lessons from past waves should guide future responses? The most important lessons are early detection, rapid response, and transparency. Strengthening healthcare infrastructure, ensuring vaccine access, and maintaining public health measures during surges are essential for staying ahead of the virus.
